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Abstract  1 
Objective To evaluate the efficacy and side effects of alfaxalone administered 2 
intramuscularly (IM) as a sedative agent in guinea pigs undergoing survey radiographs.  3 
Study design Prospective clinical trial.  4 
Animals Thirty client-owned guinea pigs  5 
Methods Following baseline assessments, 5 mg kg-1 alfaxalone was administered IM. Heart 6 
rate, arterial haemoglobin oxygen saturation, respiratory rate, rectal body temperature, 7 
palpebral reflex, response to toe and ear-pinch, righting reflex, posture, jaw tone, and reaction 8 
to manipulation were assessed before and after sedation, at 5-minute intervals. The time 9 
elapsed from onset of sedation to return of locomotion and coordinated limbs movements, the 10 
quality of recovery and the occurrence of undesired effects were observed and recorded.  11 
Results The mean ± standard deviation onset of sedation was 2.7 ± 0.6 minutes. The 12 
physiological variables stayed within normal ranges until completion of the procedure. 13 
Palpebral reflex and responsiveness to both ear and toe pinch were maintained during 14 
sedation. Neither hypoxaemia nor hypothermia were observed. The duration of sedation was 15 
29.3 ± 3.2 minutes. Sedation and recovery were uneventful and adverse effects were not 16 
observed.  17 
Conclusion and clinical relevance In conclusion, 5 mg kg-1 of IM alfaxalone represents a 18 
valuable sedation protocol for healthy guinea pigs undergoing minor non-invasive 19 
procedures. Further trials are required to investigate its cardiovascular effects, its clinical 20 
usefulness in unhealthy patients and its combined use with analgesics for procedures 21 
associated with nociception. 22 
Keywords Sedation, alfaxalone, Anaesthesia, guinea pigs 23 
 24 
25 
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Introduction  26 
Radiographic examination is an important diagnostic method to identify dental, 27 
gastrointestinal, respiratory, and urogenital conditions that are common in guinea pigs (Cavia 28 
porcellus) (Zwingerberger & Silverman 2009; Fischetti 2012). However, in order to obtain 29 
high-quality diagnostic images, sedation is frequently required to achieve immobility. Several 30 
drug combinations have been used to anaesthetize or sedate laboratory guinea pigs (Dang et 31 
al. 2008; Schmitz et al. 2016).  32 
Nevertheless, there is a paucity of literature regarding the anaesthetic management of these 33 
small rodents in a clinical context. Short-term inhalational anaesthesia with either isoflurane 34 
or sevoflurane, as well as injectable anaesthesia achieved with α-2 agonists and ketamine, 35 
alone or in combination, have both been described to obtain diagnostic imaging in rodents 36 
and small mammals (Zwingerberger & Silverman 2009; Fischetti 2012; Hawkins & Pascoe 37 
2012). However, none of them can be considered to be optimal for guinea pigs in terms of 38 
effectiveness, reliability, safety and reversibility. Inhalational agents may cause dose-39 
dependent hypotension, airway irritation and, in guinea pigs, even sudden death during 40 
procedures that may result from increased adrenergic tone (Flecknell 2009; Overholser et al. 41 
2010). Benzodiazepines result in effective sedation and immobility, but have no analgesic 42 
properties and animals can be easily aroused by nociceptive stimulation or noises (Flecknell 43 
2009). Αlpha-2-agonists have unpredictable effects in guinea pigs, when administered alone 44 
or in combination with ketamine (Richardson & Flecknell 2009). Finally, ketamine alone 45 
does result in immobilization in guinea pigs, but has been reported to cause cutaneous 46 
irritation and even muscle necrosis when administered subcutaneously or intramuscularly 47 
(IM) (Flecknell 2009; Richardson & Flecknell 2009). 48 
Alfaxalone is a neuroactive steroid derivative of pregnanedione acting on the gamma-49 
aminobutyric acid (GABA) receptors. Its effects on ileal GABA-induced contractions have 50 
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been previously investigated in guinea pigs (Ong et al. 1988). The new alfaxalone 51 
formulation with hydroxypropyl β cyclodextrin, licensed in many countries for intravenous 52 
(IV) use as an anaesthetic induction agent in dogs and cats, has been successfully used, alone 53 
or in combination with other drugs, in exotic captive species (Jones 2012). These include 54 
amphibians (McMillan & Leece 2011; Posner et al. 2013; Sladakovic & Robert 2014; Adami 55 
et al. 2015; Adami et al. 2016 a, b), reptiles (Bertelsen & Sauer 2011; Knotek 2014), and 56 
mammals (Marsh et al. 2009; Huyhn et al. 2015; d’Ovidio et al. 2015). Alfaxalone can also 57 
be administered IM to minimize stress associated with handling, physical examination, minor 58 
procedures (such as IV cannulation) and in fractious animals (Marsh et al. 2009; Huyhn et al. 59 
2015; Buisman et al. 2016; Khenissi et al. 2016). At a dose of 4-6 mg kg-1, IM alfaxalone 60 
produced a rapid and smooth anaesthetic induction in rabbits, followed by excellent recovery 61 
(Huyhn et al. 2015).  62 
The purpose of this study was to evaluate the efficacy and safety of IM alfaxalone as a 63 
sedative agent in client-owned guinea pigs undergoing survey radiographs, for screening of 64 
subclinical dental and respiratory diseases. Our hypothesis was that IM alfaxalone would 65 
produce safe and adequately deep sedation in guinea pigs, suitable for short diagnostic 66 
procedures requiring immobility.   67 
 68 
Materials and Methods 69 
Animals  70 
Thirty client-owned guinea pigs, belonging to the same breeder and scheduled for survey 71 
radiographs for screening of subclinical dental and respiratory diseases, were enrolled in this 72 
prospective clinical trial. Health status was assessed before sedation with physical 73 
examination (to assess general health conditions) and faecal examination (to detect 74 
subclinical intestinal parasitic infections). The study was conducted under approval of the 75 
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Clinical Research Ethical Review Board of the Royal Veterinary College (license number: 76 
URN 2016 1560), and signed informed owner consent. 77 
Procedures  78 
Animals were admitted 24 hours before commencing the diagnostic procedures to allow for 79 
acclimatization, and housed in groups of five littermates of the same sex in190x150x200cm 80 
cages. They were provided with pelleted guinea pig feed, ad libitum hay and water, and fresh 81 
vegetables daily. All guinea pigs were attributed an American Society of Anaesthesiologists 82 
(ASA) score based on physical and copromiscroscopic exams. Animals were not fasted 83 
before the procedure. Baseline values for heart rate (HR, from chest auscultation) pulse rate 84 
(pulse oximeter transducer), arterial haemoglobin oxygen saturation (SpO2, from pulse 85 
oximeter transducer placed digits of pelvic limb), respiratory rate (fR) from observation of 86 
thoracic excursion) and rectal temperature (T) were obtained in each guinea pig before 87 
sedation (T0). As a part of the baseline assessment, the following variables were also assessed 88 
in the awake animals: palpebral reflex, response to toe and ear-pinch, righting reflex, posture, 89 
jaw tone, and reaction to manipulation. The palpebral reflex was assessed with a gentle tactile 90 
stimulation of the upper eyelid; the possible outcomes were yes (present) or no (absent). The 91 
response to toe- and ear-pinch was evaluated by applying blunt surgical forceps, for a 92 
maximum of two seconds, at the level of the distal interphalangeal junction and of the base of 93 
the ear, respectively, with a score ranging from 0 to 2 where (0) indicated limb 94 
withdrawal/head movement immediately after pinching (intense response), (1) delayed limb 95 
withdrawal/head movement (more than 1 second after stimulus application), and (2) no 96 
response. The righting reflex was assessed after the guinea pigs had been placed by the 97 
observer in dorsal recumbency over a flat, firm surface. A 0-3 score was used, where (0) 98 
indicated that the animal regained sternal recumbency immediately after positioning, (1) it 99 
regained sternal recumbency within 5-10 seconds after positioning, (2) it attempted to regain 100 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
sternal recumbency but failed to achieve sternal position, and (3) it maintained dorsal 101 
recumbency with no attempts to reposition. Posture was evaluated with a score ranging from 102 
0 to 5, as follows: (0) normal, (1) head up but sitting, (2) head down and sternal recumbency, 103 
(3) lateral recumbency, (4) dorsal recumbency but responsive to stimulation, and (5) dorsal 104 
recumbency and no response to stimulation. Jaw tone was evaluated with a 0-2 score, where 105 
0, 1 and 2 were indicative of absent, decreased, and normal jaw tone, respectively. Finally, 106 
reaction to manipulation was assessed with a score ranging from 0 to 2, where 0 was 107 
indicative of normal reaction, 1 of decreased response, and 2 of absent response. 108 
Following baseline assessments, 5 mg kg-1 (0.5 mL kg-1) alfaxalone (Alfaxan 1%; Jurox, UK) 109 
was administered IM in the left or right quadriceps femoris. The animals were manually 110 
restrained during intramuscular injection. Time to onset of sedation, defined as the minutes 111 
elapsed from IM injection to lateral recumbency, was recorded. At this point, the diagnostic 112 
procedure was commenced. An electric heating pad (Eickwarm; Eickemeyer, Italy) was used 113 
to prevent hypothermia. During sedation, the same variables assessed during baseline 114 
evaluation were recorded at the following 7 time points: T5, T10, T15, T20, T25, T30 and 115 
T35, indicative of 5, 10, 15, 20, 25, 30 and 35 minutes after injection, respectively. Time to 116 
recovery, defined as the minutes elapsed from onset of sedation to return of locomotion and 117 
coordinated limb movements was recorded, as well as the duration of the clinical procedure 118 
(minutes). The time elapsed from onset of sedation to time of recovery was defined as 119 
duration of sedation. The occurrence of adverse effects, namely hypoxaemia (defined as 120 
SpO2< 97%), severe cardiorespiratory depression (defined as decrease in the basal values for 121 
HR and fR by 50% or more), hypothermia (T < 37.2 °C), delayed food intake (more than one 122 
hour after recovery), and gastro-intestinal disturbances observed within 72 hours of sedation, 123 
was recorded. After the end of the diagnostic procedure, the guinea pigs were allowed to 124 
recover in individual boxes in a quiet room. Fresh vegetables and drinking water were offered 125 
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at recovery and the guinea pigs were discharged from the hospital after the observation 126 
period. 127 
 128 
Statistical analyses 129 
Normality was assessed with the Kolmogorov-Smirnov test, and with the Shapiro-Wilk test. 130 
Data were then analysed with either one-way repeated measures analysis of variance, 131 
followed by Holm-Sidak method for multiple comparisons versus baseline (T0), or with 132 
Friedman repeated measures analysis of variance on ranks, followed by Tukey test for 133 
multiple comparisons, where it applied. The time point was used as group factor. 134 
Commercially available software was used for statistics (SigmaStat and SigmaPlot; Systat 135 
Software Inc., CA, USA). P values < 0.05 were considered statistically significant. Data are 136 
presented as either mean ± standard deviation or median (range), where it applies. 137 
 138 
Results  139 
A total of 15 male and 15 females guinea pigs that weighed 456 (320-930) grams and were 8 140 
(3-12) months old were enrolled in the study and judged healthy based on physical and 141 
copromiscroscopic exams. All guinea pigs were assigned an ASA classification risk I. Data 142 
for HR and onset and duration of sedation and duration of the clinical procedure were 143 
normally distributed. All the guinea pigs showed a reaction to IM injection of alfaxalone, 144 
characterized by twitches of the lumbar muscles and attempts to fight physical restraint. The 145 
onset of sedation was 2.7 ± 0.6 minutes. Heart rate significantly increased after IM alfaxalone 146 
compared to baseline (from 226 ± 26 to 235 ± 30 beats minute-1), and there was a statistically 147 
significant difference between the values recorded at T0 (baseline) and all the other time 148 
points except T15 (p <0.001). There were no statistically significant differences in T (which 149 
ranged between 37.2-39.5°C) and fR [which ranged from 85 (75-98) to 89 (78-100) breaths 150 
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minute-1] between baseline and the other time points (Figs. 1−3). All the physiological 151 
variables stayed within normal ranges for the species (Flecknell 2002; Keeble 2009) until 152 
completion of the procedure. Similarly, SpO2 remained above 96% throughout the procedure 153 
and hypoxaemia was never observed. The scores for righting reflex, reaction to manipulation 154 
and jaw tone increased, compared to baseline, during the first 15 minutes of sedation, and 155 
decreased again after T15. With respect to the aforementioned variables, there were 156 
statistically significant differences between T0 and T5, T10 and T15 (p < 0.001; Table 1). The 157 
scores for posture increased and remained higher than baseline values until T20 (p <0.001). 158 
Palpebral reflex and responsiveness to both ear and toe pinch were maintained during 159 
sedation in all animals. In all cases, the depth and the duration of sedation (29.3 ± 3.2 160 
minutes) achieved with IM alfaxalone were sufficient to allow completion of the clinical 161 
procedure, which lasted 30.0 ± 4.5 minutes. The survey radiographs did not reveal 162 
abnormalities in any of the guinea pigs enrolled in the trial. Sedation and recovery were 163 
uneventful and adverse effects were not observed. In addition, all animals showed normal 164 
appetite and regular defecation within one hour following the procedure.  165 
 166 
Discussion  167 
This study has confirmed our hypothesis that 5 mg kg-1 alfaxalone IM represents a valuable 168 
alternative to previously reported sedation protocols for guinea pigs undergoing minor 169 
clinical procedures (Zwingerberger & Silverman 2009; Fischetti 2012; Hawkins & Pascoe 170 
2012). Indeed, the effects of IM alfaxalone are species-dependent. Whilst in various 171 
mammalian species it is reported to produce reliable sedation when administered either alone 172 
or in combination with other drugs (Huyhn et al. 2015; d’Ovidio et al. 2015), in chelonians it 173 
appears to be less effective (Scheelings 2013). The depth of sedation achieved in the guinea 174 
pigs enrolled in the current study was sufficient to ensure immobility, ease to positioning and 175 
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adequate muscle relaxation for at least 15-20 minutes, which is the average time required for 176 
most diagnostic studies at our institution. The minimal standard deviation also shows 177 
consistency with respect to the rapid onset of action and the duration of the sedative effect, 178 
which may indicate predictability of this sedation protocol in guinea pigs. Moreover, 179 
respiratory function and body temperature were preserved throughout the procedure, which 180 
suggests that IM alfaxalone may be a clinically useful anaesthetic choice in healthy guinea 181 
pigs.  182 
Overall, alfaxalone provided good quality of sedation compared to other anaesthetic protocols 183 
previously described in guinea pigs. A study comparing ketamine–xylazine (administered 184 
subcutaneously, IM, or intraperitoneally), intraperitoneal pentobarbital, and IM 185 
medetomidine, found that reliable immobilization and absence of response to blood sampling 186 
were not achieved. Moreover, time to recovery ranged from 49.0 to 294.3 minutes (Dang et 187 
al. 2008). Recovery from alfaxalone sedation was smooth and uneventful, and none of the 188 
animals showed hypothermia in contrast with previous reports (Schmitz et al. 2016). 189 
It was challenging during the current study was to distinguish between deep sedation and 190 
general anaesthesia. Alfaxalone is an induction agent capable of producing both general 191 
anaesthesia and deep sedation, depending on the dose and the route of administration. 192 
However, sedation is commonly regarded as the preferred option for non-invasive clinical 193 
procedures of short duration in small animals, and very often owners raise some concerns 194 
when general anaesthesia is proposed instead. In order to define the anaesthetic effects of IM 195 
alfaxalone, it was decided to evaluate both righting reflex and posture. In laboratory rodents, 196 
the loss of righting reflex is unarguably considered the cut off parameter between sedation 197 
and anaesthesia, as it is believed to imply unconsciousness (Flecknell 2009). Whilst certain 198 
diagnostic procedures do not necessarily require unconsciousness, other features are desirable 199 
for the purpose of obtaining good quality images, especially when procedures carrying a 200 
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potential risk for personnel safety (e.g. radiographic examinations) are to be performed. 201 
Among these features, adequate sedation and muscle relaxation are desired to achieve ease to 202 
positioning and immobility. The guinea pigs remained in lateral recumbency for a period up 203 
to 20 minutes in the absence of stimulation, but most of them tended to regain their righting 204 
reflex within 15 minutes after injection. This seems to indicate that unconsciousness - and 205 
therefore general anaesthesia - may be achieved in guinea pigs after IM alfaxalone at the dose 206 
investigated in this study, but the anaesthetic effects wear off progressively, transitioning to a 207 
state of deep sedation. Increasing the alfaxalone dose may deepen or prolong its anaesthetic 208 
effects in guinea pigs. However, investigating the effect of a higher doses was beyond the 209 
aims of this study.  210 
Increasing the dose of IM alfaxalone would also increase the risk for cardiorespiratory side 211 
effects, as has been demonstrated in dogs, cats and rabbits (Huynh et al. 2015; Tamura et al. 212 
2015a; Tamura et al. 2015b). Moreover, because alfaxalone is only available in Europe at a 213 
concentration of 10 mg mL-1 doses higher than 5 mg kg-1 would result in unacceptably high 214 
IM injection volumes for small rodents. It has been demonstrated that histopathological 215 
lesions of the skeletal muscles may result not only from the drug's chemical characteristics, 216 
but also from mechanical compression when large volumes are injected (Evans 2005; 217 
Thuillez et al. 2009). This represents a major limitation when dealing with smaller mammals 218 
and, as previously advocated by other investigators, the commercialization of more 219 
concentrated solutions might partially overcome this issue (Tamura et al. 2015 b).  220 
All the guinea pigs showed a behavioural reaction to IM injection of alfaxalone. However, 221 
whether this reaction was caused by the drug itself or by the needle insertion cannot be 222 
determined. No adverse reactions (e.g. self mutilation) were noticed in the present study in 223 
the days following the procedure. However, one drawback of alfaxalone compared to other 224 
injectable agents is the lack of reversibility of the effects, as no antagonists were available at 225 
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the time of writing. 226 
All the guinea pigs maintained unaltered response to both ear and toe pinch throughout the 227 
procedure, which indicates that analgesia was not achieved. This limits the clinical of 228 
alfaxalone as a sole agent to minor, non-invasive clinical procedures.  229 
Although to the best of the authors’ knowledge no pulse oximetry device has been validated 230 
for guinea pigs, the fact that SpO2 remained above 96% may indicate that severe hypoxaemia 231 
did not occur despite the lack of oxygen supplementation. As rodents are predisposed to 232 
respiratory diseases, the use of anaesthetic agents with minimal impact on the respiratory 233 
function is essential.  234 
Despite increased HR after administration of alfaxalone, the measured cardiorespiratory 235 
variables were within normal reference ranges for the species (Flecknell 2002; Keeble 2009), 236 
with no remarkable changes, in the majority of the animals enrolled. With respect to the 237 
cardiovascular function, it is worth to consider that a more comprehensive evaluation of the 238 
latter would imply at least the monitoring of the arterial blood pressure. Previous studies 239 
conducted in cats and dogs have shown that doses of alfaxalone higher than 5 mg kg-1 caused 240 
cardiovascular depression characterised by decreased mean arterial pressure in the absence of 241 
changes in the heart rate (Tamura et al. 2015a; Tamura et al. 2015b). Unfortunately, 242 
monitoring of systemic arterial blood pressure was not performed in this study.  243 
The guinea pigs recruited for this study were aged 8 (3-12) months and were purchased from 244 
the same breeder. Considering that guinea pigs become sexually mature at the age of 3 245 
months, the study population was mainly composed of adults, with a few younger animals. 246 
This may represent an unintentional selection bias, as in the present study the protocol was 247 
not tested against the neonates or geriatric animals, in which alfaxalone may have sensibly 248 
different pharmacokinetics and pharmacodynamics. Moreover, the same origin of the animals 249 
may imply a similar genetic background, an aspect which may limit the validity of our 250 
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findings to a sample poorly representative of guinea pigs in general.  251 
In conclusion, IM alfaxalone may represent a useful means to provide deep sedation 252 
with minimal side effects to healthy guinea pigs undergoing diagnostics and minor non-253 
invasive procedures. Further trials are required to investigate its cardiovascular effects, its 254 
clinical usefulness in unhealthy patients and its combined use with analgesics for invasive 255 
procedures. Finally, studies recruiting animals coming from different populations should be 256 
encouraged to investigate the inter-individual variability.  257 
 258 
 259 
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Figure 2 Means and standard deviations of respiratory rates, measured by direct visualization of 
the thoracic excursion before and after intramuscular injection of alfaxalone, in 30 guinea pigs 
undergoing survey radiographic examination. T5, T10, T15, T20, T25, T30 and T35 are minutes 
after injection; T0 is the baseline (before injection). 
 
Figure 3 Means and standard deviations of heart rates, measured by thoracic auscultation before 
and after intramuscular injection of alfaxalone, in 30 guinea pigs undergoing survey radiographic 
examination. T5, T10, T15, T20, T25, T30 and T35 are minutes after injection; T0 is the baseline 
(before injection). 
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Table 1 Variables assessed during sedation with 5 mg kg-1 intramuscular alfaxalone in thirty 
guinea pigs undergoing survey radiographic exam. The time points T5, T10, T15, T20, T25, 
T30 and T35 are minutes after injection and n is the number of animals in which the clinical 
procedure was completed at the respective time point. Data are reported as median (range). 
 
Timepoint Righting 
reflex  
(0-3) 
Reaction 
to 
manipulati
on 
(0-2) 
Jaw tone 
 (0-2) 
Posture  
(0-5) 
Palpebr
al 
reflex 
(yes or 
no) 
Response 
to ear 
pinch 
(0-2) 
Response 
to toe 
pinch 
(0-2) 
T0 (n=30) 0 (0-1) 0 (0-1) 2 (1-2) 0 (0-4) yes 0 (0-0) 0 (0-0) 
T5 (n=30) 2 (1-2) * 2 (1-2) * 1 (1-2) * 4 (3-5) * yes 0 (0-0) 0 (0-0) 
T10 (n=30) 2 (1-2) * 2 (1-2) * 1 (1-1) * 4 (4-5) * yes 0 (0-0) 0 (0-0) 
T15 (n=30) 2 (1-2) * 2 (1-2) * 1 (0-1) * 4 (3-5) * yes 0 (0-0) 0 (0-0) 
T20 (n=30) 1 (1-1) 1 (1-1) 1 (1-2) 3 (3-4) yes 0 (0-0) 0 (0-0) 
T25 (n=27) 0 (0-1) 0 (0-1) 2 (1-2) 2 (1-3) yes 0 (0-0) 0 (0-0) 
T30 (n=18) 0 (0-1) 0 (0-1) 2 (1-2) 0.5 (0-1) yes 0 (0-0) 0 (0-0) 
T35 (n=6) 0 (0-1) 0 (0-1) 2 (1-2) 0.5 (0-1) yes 0 (0-0) 0 (0-0) 
 
*Significantly different from baseline (T0). Righting reflex ranged from (0) the animal 
regained sternal recumbency immediately after positioning, to (3) it maintained dorsal 
recumbency with no attempts to reposition. Reaction to manipulation ranged from (0) normal 
reaction to (2) absent response. Jaw tone ranged from (0) absent to (2) normal. Posture 
ranged from (0) normal to (5) dorsal recumbency and no response to stimulation. Response to 
ear pinch and toe pinch ranged from (0) intense response to (2) no response. 
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Figure 1: Means and standard deviations of rectal body temperature, measured before and 
after intramuscular injection of alfaxalone, in 30 Guinea pigs undergoing survey radiographic 
examination. T5, T10, T15, T20, T25, T30 and T35 are minutes after injection; T0 is the 
baseline (before injection). 
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